Key Points:
1.The National Health Surveillance Agency of Brazil received an award from the World Health Organization for banning e-cigarettes.
2.Research data shows that the usage rate of e-cigarettes among Brazilian adults is projected to increase by 24% in 2024.
3.The ban on e-cigarettes in Brazil has contributed to significantly lower levels of e-cigarette usage compared to other countries.
4.Brazil has launched anti-smoking campaigns and expanded treatment methods to actively combat emerging challenges.
According to Brazilian media portal Tela on May 28th, Brazil's National Health Surveillance Agency (Anvisa) was awarded the World No Tobacco Day prize from the World Health Organization (WHO) for its outstanding contributions to tobacco regulations and the prohibition of e-cigarettes. The award ceremony took place at the headquarters of the Pan American Health Organization (Opas) in Brasilia. Anvisa Director Danitza Buvinich emphasized that the ban on e-cigarettes is an important measure to protect public health.
On the same day, a study conducted by the Brazilian National Cancer Institute (Inca) found that by 2024, the use of e-cigarettes among adults had increased by 24%, while the use of traditional tobacco had grown by 25%, reaching 13.8% of the national population. These figures are seen as a setback for anti-smoking policies.
Health Minister Alexandre Padilha emphasized the importance of continuing to implement Anvisa's resolution banning the sale and promotion of e-cigarettes. He stated that the number of people using e-cigarette devices in Brazil is far lower than in countries that have legalized these products. Research also shows that smoking costs Brazil 153.5 billion reais ($27.1 billion) annually, representing 1.55% of the gross domestic product.
In order to raise public awareness, especially among young people, the Brazilian Ministry of Health has initiated a campaign called "Smoke-Free Life, Healthy Future". The campaign aims to alert people to the potential risks of e-cigarettes and their additives. According to data, the usage rate of e-cigarettes among young people aged 18 to 24 is as high as 6.1%.
Additionally, Brazil's Unified Health System (SUS) is expanding the accessibility and variety of smoking cessation treatments. Between 2022 and 2024, related medical services increased by 96.4%, reflecting Brazil's efforts in smoking prevention and treatment.
Brazil was one of the earliest countries to join the WHO Framework Convention on Tobacco Control.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
